Louis G. Lange - 13 Feb 2024 Form 4 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Director
Signature
/s/ Louise Kooij by Power of Attorney from Louis G. Lange
Issuer symbol
NAMS
Transactions as of
13 Feb 2024
Net transactions value
+$95,000
Form type
4
Filing time
21 Feb 2024, 17:00:25 UTC
Previous filing
03 Jan 2024
Next filing
08 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAMS Ordinary Shares Purchase $95,000 +5,000 +25% $19.00 24,878 13 Feb 2024 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents ordinary shares acquired from the Company in an underwritten public offering. The ordinary shares acquired from the Company were placed into and are being held in a trust account for the benefit of the Reporting Person.